Kd (dissociation constant) determination for 17-AAG and compound D binding to PfHSP90.

JG Judith L. Green
RM Robert W. Moon
DW David Whalley
PB Paul W. Bowyer
CW Claire Wallace
AR Ankit Rochani
RN Rishi K. Nageshan
SH Steven A. Howell
MG Munira Grainger
HJ Hayley M. Jones
KA Keith H. Ansell
TC Timothy M. Chapman
DT Debra L. Taylor
SO Simon A. Osborne
DB David A. Baker
UT Utpal Tatu
AH Anthony A. Holder
request Request a Protocol
ask Ask a question
Favorite

Tryptophan fluorescence analysis was performed using a PerkinElmer LS55 luminescence spectrometer. In order to determine the binding affinity of purified recombinant proteins, 25 μg/ml PfHSP90 or PfHSP90 N-terminal domain (PfHSP90-NTD) was incubated with concentrations of 17-N-allylamino-17-demethoxygeldanamycin (17-AAG) or compound D ranging from 0 to 60 μM. The binding buffer used for the reaction contained 50 mM Tris-HCl, pH 7.4, and 1 mM EDTA. Samples were excited at 280 nm, and tryptophan fluorescence measurements were carried out by scanning the emission spectrum in the wavelength range 300 to 400 nm. A maximum wavelength (λmax) of 346 nm was selected for all the calculations. The slit widths of excitation and emission were set at 2.5 and 5 nm, respectively. The difference in fluorescence intensity between protein alone and protein with various concentrations of 17-AAG or compound D was calculated and plotted against the different concentrations of the respective ligand used. The resultant hyperbolic curve was analyzed with GraphPad Prism software, using nonlinear regression analysis with single-site-specific binding as described previously (32).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A